Madrigal Pharmaceuticals' Rezdiffra had a strong launch with $103.3M in Q4 sales and solid liquidity. See why I have a ...

BofA raised the firm’s price target on Madrigal Pharmaceuticals (MDGL) to $239 from $154 and keeps an Underperform rating on ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on 89bio (ETNB – Research Report) and Lemaitre ...

Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...

Leon’s Furniture (TSE:LNF – Get Free Report) had its price target cut by equities researchers at Royal Bank of Canada from C$32.00 to C$31.00 in a research note issued on Thursday,BayStreet.CA reports ...

Healthcare & Pharmaceuticalscategory Lilly plans to invest $27 billion in new US plants as Trump threatens pharmaceutical tariffs February 26, 2025 ...